Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Suraksha Diagnostic IPO is a book build issue of ₹846.25 crores. The issue is entirely an offer for sale of 1.92 crore shares of ₹846.25 crore.
Suraksha Diagnostic IPO bidding started from Nov 29, 2024 and ended on Dec 3, 2024. The allotment for Suraksha Diagnostic IPO was finalized on Dec 4, 2024. The shares got listed on BSE, NSE on Dec 6, 2024.
Suraksha Diagnostic IPO price band is set at ₹441.00 per share . The lot size for an application is 34. The minimum amount of investment required by an retail is ₹14,280 (34 shares). The lot size investment for sNII is 14 lots (476 shares), amounting to ₹2,09,916, and for bNII, it is 67 lots (2,278 shares), amounting to ₹10,04,598.
ICICI Securities Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue.
Refer to Suraksha Diagnostic IPO RHP for detailed Information.
| IPO Date | November 29, 2024 to December 3, 2024 |
| Listing Date | December 6, 2024 |
| Face Value | ₹2 per share |
| Issue Price Band | ₹420 to ₹441 per share |
| Issue Price Final | ₹441 per share |
| Lot Size | 34 Shares |
| Sale Type | Offer For Sale |
| Total Issue Size | 1,91,89,330 shares (aggregating up to ₹846.25 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 5,20,80,758 shares |
| Share Holding Post Issue | 5,20,80,758 shares |
Suraksha Diagnostic IPO offers total 1,91,89,330 shares. Out of which 95,94,664 (50.00%) allocated to QIB, 38,37,867 (20.00%) allocated to QIB, 28,78,400 (15.00%) allocated to NII, 67,16,266 (35.00%) allocated to RII and 57,56,797 (30.00%) allocated to Anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| QIB Shares Offered | 95,94,664 (50.00%) | NA |
| − Anchor Investor Shares Offered | 57,56,797 (30.00%) | NA |
| − QIB (Ex. Anchor) Shares Offered | 38,37,867 (20.00%) | NA |
| NII (HNI) Shares Offered | 28,78,400 (15.00%) | NA |
| − bNII > ₹10L | 19,18,934 (10.00%) | 4,031 |
| − sNII < ₹10L | 9,59,466 (5.00%) | 2,015 |
| Retail Shares Offered | 67,16,266 (35.00%) | 1,97,537 |
| Total Shares Offered | 1,91,89,330 (100.00%) |
Suraksha Diagnostic IPO raises ₹253.87 crore from anchor investors. Suraksha Diagnostic IPO Anchor bid date is November 28, 2024. Suraksha Diagnostic IPO Anchor Investors list
| Bid Date | November 28, 2024 |
| Shares Offered | 57,56,797 |
| Anchor Portion Size (In Cr.) | 253.87 |
| Anchor lock-in period end date for 50% shares (30 Days) | January 3, 2025 |
| Anchor lock-in period end date for remaining shares (90 Days) | March 4, 2025 |
Suraksha Diagnostic IPO opens on November 29, 2024, and closes on December 3, 2024.
| IPO Open Date | Fri, Nov 29, 2024 |
| IPO Close Date | Tue, Dec 3, 2024 |
| Tentative Allotment | Wed, Dec 4, 2024 |
| Initiation of Refunds | Thu, Dec 5, 2024 |
| Credit of Shares to Demat | Thu, Dec 5, 2024 |
| Tentative Listing Date | Fri, Dec 6, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on Tue, Dec 3, 2024 |
Investors can bid for a minimum of 34 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 34 | ₹14,994 |
| Retail (Max) | 13 | 442 | ₹1,94,922 |
| S-HNI (Min) | 14 | 476 | ₹2,09,916 |
| S-HNI (Max) | 66 | 2,244 | ₹9,89,604 |
| B-HNI (Min) | 67 | 2,278 | ₹10,04,598 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 2005, Suraksha Diagnostic Limited offers pathology, radiology testing and medical consultancy services. The company has a central reference laboratory with 8 satellite laboratories and 215 customer touchpoints, including 49 diagnostic centres and 166 sample collection centres as of June 30, 2024, across West Bengal, Bihar, Assam, and Meghalaya.
The company offers its customers online and offline medical consultation services under one roof via 44 diagnostic centres, which house 120 polyclinics with more than 750 doctors.
The operation of the diagnostic centres is supported by the technology platforms and systems that the company uses to streamline, such as its Laboratory Information Management System ("LIMS"), its fully integrated Radiology Information System ("RIS"), its Picture Archive Communication System ("PACS") and its Enterprise Resource Planning System ("ERP").
The company offers vaccination services and customized testing packages for disease prediction/early detection. The company uses digital pathology and artificial intelligence to generate blood tests. All radiology reporting is done through a digital platform that allows cases to be reported from all diagnostic centres, significantly reducing turnaround time.
Competitive Strengths are:
Suraksha Diagnostic Limited's revenue increased by 14.75% and profit after tax (PAT) rose by 281.32% between the financial year ending with March 31, 2024 and March 31, 2023.
| Period Ended | 30 Jun 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 314.20 | 300.21 | 281.20 | 275.96 |
| Total Income | 61.85 | 222.26 | 193.69 | 225.77 |
| Profit After Tax | 7.67 | 23.13 | 6.07 | 20.82 |
| Net Worth | 187.05 | 179.41 | 155.93 | 145.84 |
| Reserves and Surplus | 176.80 | 170.88 | 147.40 | 137.31 |
| Total Borrowing | 7.57 | 8.64 | 14.01 | 19.03 |
| Amount in ₹ Crore | ||||
The market capitalization of Suraksha Diagnostic IPO is ₹2296.76 Cr.
KPI as of Sun, Mar 31, 2024.
| KPI | Values |
|---|---|
| ROE | 14.09% |
| ROCE | 21.46% |
| Debt/Equity | 0.20 |
| RoNW | 14.09% |
| PAT Margin | 10.57% |
| Price to Book Value | 13.10 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS Rs | 4.44 | 5.89 |
| P/E (x) | 99.31 | 74.89 |
The Company will not receive any proceeds from the Offer for sale and all proceeds will go to the Selling Shareholders.
[Dilip Davda] The company is a one-stop pathology and radiology testing, and medical consultation services solution provider having East region centric play. It enjoys market share of around 1.26% in the area of its operation and that is scaling up with its new centre opening, which adds to its top line and over the period start contributing to its bottom line. It suffered a minor setback for FY23 due to non-contribution of such centres opened in FY22 and their related expenses. However, the company is back on track as indicated by FY24 performance and is poised for bright prospects with its expansion plans afoot. Based on FY25 annualized earnings, the issue appears fully priced discounting all near term positives. However, well-informed investors may park funds for long term. Read detail review...
| Listing Date | December 6, 2024 |
| BSE Script Code | 544293 |
| NSE Symbol | SURAKSHA |
| ISIN | INE877V01027 |
| Final Issue Price | ₹441 per share |
| NSE Listing Group | EQ (Rolling) |
| BSE Listing Group | B |
Suraksha Diagnostic Ltd.
Plot No. DG-12/1
Action Area 1D, Premises No. 02-0327
New Town, Rajarhat Kolkata 700 156
Kolkata, West Bengal
Phone: 91 33 66059750
Email: investors@surakshanet.com
Website: https://www.surakshanet.com/
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: sdl.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/
Suraksha Diagnostic IPO is a main-board IPO of 1,91,89,330 equity shares of the face value of ₹2 aggregating up to ₹846.25 Crores. The issue is priced at ₹441 per share. The minimum order quantity is 34.
The IPO opens on November 29, 2024, and closes on December 3, 2024.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Suraksha Diagnostic IPO using UPI as a payment gateway. Zerodha customers can apply in Suraksha Diagnostic IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Suraksha Diagnostic IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Suraksha Diagnostic IPO opens on November 29, 2024 and closes on December 3, 2024.
Suraksha Diagnostic IPO lot size is 34, and the minimum amount required for application is ₹14,994.
You can apply in Suraksha Diagnostic IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Suraksha Diagnostic IPO will be done on Wednesday, December 4, 2024, and the allotted shares will be credited to your demat account by Thursday, December 5, 2024. Check the Suraksha Diagnostic IPO allotment status.
The Suraksha Diagnostic IPO listing date is on Friday, December 6, 2024.
Useful Articles
RHP